Prof. Dr. Markus Golling, Das DIAK – Diakonieklinikum – Klinik für Allgemein- und Viszeralchirurgie, Germany.
Prof. Markus Theodor Golling 🎓, a distinguished surgeon-scientist from Germany, specializes in visceral, vascular, and transplant surgery. With training from RCSI and Tübingen University, he holds multiple board certifications and a habilitation (MD, PhD). He has led numerous clinical trials, reviewed for top journals 📝, and received awards like the Abraham Buschke Award 🏅. His academic travels span Europe, Asia, and the Middle East 🌍, marking him as a globally respected leader in surgical research and education.
Profile
Scopus Profile
Google Scholar Profile
🎓 Early Academic Pursuits
Dr. Markus Theodor Golling began his medical journey at the prestigious Royal College of Surgeons in Ireland (1981–83) before transferring to Eberhard Karls University in Tübingen, Germany (1984–89). His early education laid a robust foundation in surgical medicine. This period was characterized by a strong commitment to academic rigor and international exposure, fueling his future career in advanced surgery and research. 🏫📚
💼 Professional Endeavors
Dr. Golling has held several pivotal positions in renowned medical institutions across Germany. He began his clinical training in traumatology, emergency, plastic, and vascular surgery in Nürnberg. He later advanced through surgical disciplines at the Ruprecht-Karls-University, Heidelberg, contributing to visceral, vascular, and transplantation surgery. His board certifications in General Surgery (1997), Visceral Surgery (2002), and Vascular Surgery (2005) highlight his broad surgical expertise. He currently serves in the Department of General and Visceral Surgery at Das DIAK, DAIKONEO hospital, Schwäbisch Hall, a teaching hospital affiliated with Heidelberg University. 🩺🏨
🔬 Contributions and Research Focus On Surgery
Dr. Golling’s research spans transplantation surgery, oncology, hernia prevention, and neoadjuvant therapy. He has been the principal investigator and contributor to clinical trials involving chemotherapy regimens, liver metastasis management, and surgical site infection prevention. His innovative participation in landmark trials such as PETACC II, EPOC, CLOCC, and PRIMA demonstrates his commitment to improving surgical outcomes and patient care. 🧪🔍
🌍 Impact and Influence
Through global academic visits to institutions in Japan, France, the UK, Hungary, Brazil, and Saudi Arabia, Dr. Golling has contributed to international knowledge exchange and surgical training. His work in telemedicine, laparoscopic surgery, and metabolic disorders has enhanced global surgical practices. His roles as Board Examiner and Final Medical Examiner in Surgery have influenced the education of future surgeons. 🌐💡
🧠 Research Skills
Dr. Golling possesses expertise in clinical trial design, surgical innovation, and multicenter collaborations. His skills extend to advanced laparoscopic techniques, oncologic resection protocols, and biomaterials for hernia repair. Multilingual and equipped with administrative training from the Baden-Württemberg Academy, he bridges clinical science with operational excellence. 🧠🧵
🏅 Awards and Honors
Dr. Golling’s contributions have earned him numerous accolades, including the Up-John Prize (1984), Abraham Buschke Award (2001), Fujisawa Young Investigator Award (2002), and JSPS Fellowship. His achievements underscore a career marked by excellence and innovation in surgery and research. 🏆🎓
🏛️ Legacy and Future Contributions
Dr. Golling possesses expertise in clinical trial design, surgical innovation, and multicenter collaborations. His skills extend to advanced laparoscopic techniques, oncologic resection protocols, and biomaterials for hernia repair. Multilingual and equipped with administrative training from the Baden-Württemberg Academy, he bridges clinical science with operational excellence. 🧠🧵
Publications Top Notes
📘 Towards a Pan-European Consensus on the Treatment of Patients with Colorectal Liver Metastases
📌 European Journal of Cancer
📅 2006 📈 826 citations
✍️ Co-authors: E. Van Cutsem, B. Nordlinger, R. Adam, et al.
📘 Acute Cholecystitis: Early versus Delayed Cholecystectomy (ACDC Study)
📌 Annals of Surgery
📅 2013 📈 607 citations
✍️ Co-authors: CN Gutt, J Encke, JC Harnoss, et al.
📘 Does Chemotherapy Prior to Liver Resection Increase the Potential for Cure in Metastatic Colorectal Cancer?
📌 European Journal of Cancer
📅 2007 📈 373 citations
✍️ Co-authors: B. Nordlinger, E. Van Cutsem, CH Köhne, et al.
📘 PRIMA Trial: Prevention of Incisional Hernia in Midline Laparotomies
📌 The Lancet
📅 2017 📈 327 citations
✍️ Co-authors: AP Jairam, L Timmermans, HH Eker, et al.
📘 Relaparotomy Risk in Crohn’s Disease Based on Disease Pattern and Surgeon Factor
📌 Annals of Surgery
📅 1996 📈 183 citations
✍️ Co-authors: S. Post, C. Herfarth, H. Schumacher, et al.
📘 SYNCHRONOUS Trial: Resection vs. No Resection in Colon Cancer with Unresectable Metastases
📌 BMC Cancer
📅 2012 📈 153 citations
✍️ Co-authors: NN Rahbari, F. Lordick, D. Jäger, et al.
📘 Surgical Therapy for Recurrence and Metastasis in Gastric Cancer
📌 European Journal of Surgical Oncology (EJSO)
📅 2002 📈 95 citations
✍️ Co-authors: T. Lehnert, B. Rudek, K. Buhl
📘 Nutritional Support after Open Liver Resection: A Systematic Review
📌 Digestive Surgery
📅 2006 📈 90 citations
✍️ Co-authors: B. Richter, TC Schmandra, WO Bechstein
📘 Experience with Ileostomy and Colostomy in Crohn’s Disease
📌 British Journal of Surgery
📅 1995 📈 74 citations
✍️ Co-authors: S. Post, CH Herfarth, G. Schürmann, et al.
📘 Does the Liver Ever Age? Liver Transplantation with Donors Above 80 Years
📌 Transplantation Proceedings
📅 2005 📈 73 citations
✍️ Co-authors: C. Zapletal, D. Faust, C. Wullstein, et al.